. . . . . . . . . . . . "[The median survival was longer for patients with caspase-3 positive carcinomas than for those with caspase-3-negative tumors (41 vs 87 weeks, p = 0.038).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:38:18+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .